Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats
about
Pharmacology of hallucinations: several mechanisms for one single symptom?Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortexGroup II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortexCircuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaActivation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaAn animal model of emotional blunting in schizophrenia.Dysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14)A Role for Oxytocin in the Etiology and Treatment of Schizophrenia.Too little and too much: hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits.Targeting glutamate synapses in schizophreniaAcute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?Differential representation of Pavlovian-instrumental transfer by prefrontal cortex subregions and striatumImaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyFine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotionProgression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.More is less: a disinhibited prefrontal cortex impairs cognitive flexibilityRole of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's diseaseGroup II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.Therapeutic potential of metabotropic glutamate receptor modulators.Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats.Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation.Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugsRelationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans.Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs.Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
P2860
Q21284720-FB441E43-3091-4500-8314-34E4A728A84AQ24602550-281580DD-1C7E-4FEE-A61F-D7879E40245EQ24612550-ECA8E700-BBC3-45D1-ADE0-5B2B7605B32EQ24646206-4AA77F44-0AEA-4824-88A3-B97CEC8DE49BQ24652204-B200AA5B-879A-47D6-8786-DFEEB7D5C870Q26864995-9DE4F9BA-DCFC-471C-9A0E-499C2CFB4DF6Q28081110-4245437A-B81E-4F43-A589-20111713DA0EQ28471824-0DDF92E1-8532-4854-8FD4-593794C7E85EQ28537948-A897F2DC-D4E0-4175-91AD-140F5AEE1897Q30408983-AB585EB6-5043-4886-9B50-CEA675922ACAQ30436783-4B49CBDA-D886-4A82-B8AD-B8425B45B9AAQ30460392-FE9E7153-1943-40CB-88DE-EA2BC3DDBC59Q30466734-31B00E39-0BE7-4A98-8C73-1CC2821DBAB1Q30473410-76FEFDB3-8CB9-4780-A749-1F30742607B2Q30564474-D3DC56BC-97A4-463A-9F94-FAB07CF6B16DQ30841490-E1EA3B3A-E0BB-4F21-990B-304A6512BBA0Q33604654-51A79AA6-3914-4D4E-BE1F-326BC51C707DQ33812982-22B902FD-8656-4DA7-9217-E7A7623AF3FBQ33854844-ACD05765-92B6-451D-920E-B2A3986E37ABQ33930038-7AC16DE6-CB00-49D0-A82D-61A187AD491EQ34021750-29EB39A1-3997-4D8C-B4C6-B6CF613FD6D7Q34197064-4854A6CF-AD90-477E-8CE2-DBCA28503221Q34197072-D312DACD-DD06-470D-A662-8064DF424B2FQ34197127-6B4C941C-9814-4052-8B37-654D0257783FQ34451402-0F4D5ADA-F493-4242-9F6A-D2A2947855A5Q34632695-359A8F6A-E51E-4F77-8368-BFB99921D240Q34675038-6D3177D0-BD7E-4CFB-A0AB-3295AAAEF672Q34777486-6F52E623-5288-4DC1-B19A-8A5135D6315CQ34953049-7AC03019-EC6F-4C11-9983-2F5CB6B42DB9Q35164101-DE86E831-8EF3-4A31-90B2-E69AF7809CA4Q35738531-F2F3CD51-CC66-47E8-BB1D-63C5CE125EECQ35778704-55A83F64-6D4C-4598-91E2-0B4E563CB92EQ36034719-FEAD462E-13E9-4245-97B1-7DFB080C8CA4Q36492240-BC16C6E8-70EC-4114-BC89-02FD40CD464DQ36493481-44D03845-698C-49EB-B24D-4EF2D3AA9FC6Q36821450-B3D6C6F8-0454-41B7-8047-D9F9D5FFABDCQ36860053-DCFBFEA5-AB20-406C-8F82-E2D848C5A783Q36956907-750CCD2C-7DB4-4962-B777-854C18A952A4Q36976781-D969F086-08BD-43C5-A88E-5AA08FC46AA8Q37002862-F72682B1-8EEB-42A2-8861-A99DDE868872
P2860
Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Activation of metabotropic glu ...... ex unit activity in awake rats
@ast
Activation of metabotropic glu ...... ex unit activity in awake rats
@en
Activation of metabotropic glu ...... ex unit activity in awake rats
@nl
type
label
Activation of metabotropic glu ...... ex unit activity in awake rats
@ast
Activation of metabotropic glu ...... ex unit activity in awake rats
@en
Activation of metabotropic glu ...... ex unit activity in awake rats
@nl
prefLabel
Activation of metabotropic glu ...... ex unit activity in awake rats
@ast
Activation of metabotropic glu ...... ex unit activity in awake rats
@en
Activation of metabotropic glu ...... ex unit activity in awake rats
@nl
P2860
P3181
P356
P1476
Activation of metabotropic glu ...... ex unit activity in awake rats
@en
P2093
Houman Homayoun
Mark E Jackson
P2860
P304
P3181
P356
10.1152/JN.00875.2004
P407
P577
2005-04-01T00:00:00Z